Coverage rates for diphtheria,tetanus,poliomyelitis,and pertussis age-specific booster recommendations in France:2018 update of the real-world cohort analysis  

作　　者：Régis Verdier Clarisse Marchal Manon Belhassen Marie Le Pannerer Nicole Guiso Robert Cohen 

机构地区：[1]Sanofi,Lyon,France [2]PELyon(Pharmaco Epidemiology Lyon),Lyon,France [3]Independent Expert,Paris,France [4]UniversitéParis Est,IMRB-GRC GEMINI,Créteil,France [5]Clinical Research Center(CRC),Centre Hospitalier Intercommunal de Créteil,Créteil,France [6]GPIP,Pediatric Infectious Disease Group,France [7]ACTIV,Pediatric Clinical and Therapeutical Association of the Val de Marne,Saint-Maur des Fossés,France [8]UnitéCourt Séjour,Petits Nourrissons,Service de Néonatologie,Centre Hospitalier Intercommunal de Créteil,Créteil,France

出　　处：《Infectious Medicine》2023年第1期51-56,共6页感染医学（英文）

基　　金：The study was funded by Sanofi,Lyon,France.

摘　　要：The French National Immunization Program was updated in 2013 for vaccination against diphtheria,tetanus,per-tussis,and poliomyelitis.Our previous findings on the evolution of age-specific booster vaccination coverage rates(VCRs)up to 2017 suggested suboptimal vaccination coverages due to the pre-2013 recommendation-residual vaccination practices.In the current analysis,we evaluated all age-specific booster VCR and distribution of age at vaccination visits in 2018.In this retrospective observational cohort study,the cumulative booster VCRs were updated at all vaccination visits up to 2018 among the people who were eligible for a booster vaccination,using a 1/97th random sample of French national healthcare reimbursement databases.The cumulative booster VCR for individuals from all age groups increased from 2017 to 2018,except for 85-years-old vaccination visit.Majority of the individuals from all age groups were vaccinated(boosted)with a vaccine containing the pertussis valence.In 2018,sharp peaks corresponding to the recommended ages for booster vaccination visits were observed for individuals aged 6,11 to 13,25,45,and 65 years.Our study reiterates suboptimal coverages in France and implies the need for booster vaccination throughout life for the protection of the population.

关 键 词：Booster vaccine DTaP-IPV FRANCE PERTUSSIS National Immunisation Programme Vaccination coverage rate 

分 类 号：R186[医药卫生—流行病学]